Monopar Therapeutics Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 318.6%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares experienced significant volatility, with trading resuming and then being halted again due to a circuit breaker as the stock surged by 318.6%.
October 24, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics shares surged by 318.6%, leading to a trading halt due to a circuit breaker. This indicates significant investor interest and potential volatility in the stock.
The stock's massive increase of 318.6% suggests strong investor interest or news that has significantly impacted the stock price. The circuit breaker halt indicates high volatility, which could lead to further price movements in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100